This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Strokes are affecting approximately 1.8 million people annually
Approval is based on Phase III INAVO120 results, showing the Itovebi (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting
Aims to achieve CDMO sales of US$ 400 million by 2028
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
Subscribe To Our Newsletter & Stay Updated
